WallStreetZenWallStreetZen

NASDAQ: BPMC
Blueprint Medicines Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Blueprint Medicines earnings were -$67.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest BPMC earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$50.0M, down 11.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BPMC reported annual earnings of -$67.1M, with -86.8% growth. The next BPMC earnings date is Apr 30, 2025.

BPMC earnings history

Current Revenue
$508.8M
Current Earnings
-$67.1M
Current Profit Margin
-13.2%

BPMC Return on Equity

Current Company
-21.6%
Current Industry
-2%
Current Market
34.1%
BPMC's Return on Equity (-21.6%)... subscribe to Premium to read more.
High Return on Equity Performance

BPMC undefined

Current Company
-5.8%
Current Industry
-0.4%
BPMC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BPMC announces earnings.

BPMC undefined

Current Company
-4.1%
Current Industry
5.9%
BPMC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BPMC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BPMC-$11.50M-$67.09MN/A-$1.07
SRPT$314.67M$235.24MN/A$2.47
TLX$58.49M$31.40MN/AN/A
VRNA-$138.53M-$173.42MN/A-$2.16
AXSM-$271.22M-$287.22MN/A-$5.99
View Top Biotech Stocks

BPMC earnings dates

Next earnings date
Apr 30, 2025

Blueprint Medicines Earnings Reports & History FAQ

What were Blueprint Medicines's earnings last quarter?

On BPMC's earnings call on Invalid Date, Blueprint Medicines (NASDAQ: BPMC) reported Q4 2024 earnings per share (EPS) of -$0.80, up 56.04% year over year. Total BPMC earnings for the quarter were -$49.96 million. In the same quarter last year, Blueprint Medicines's earnings per share (EPS) was -$1.82.

If you're new to stock investing, here's how to buy Blueprint Medicines stock.

When does Blueprint Medicines report earnings?

The next BPMC earnings call is Invalid Date. Add BPMC to your watchlist to be reminded of Blueprint Medicines's next earnings date.

Is Blueprint Medicines profitable or losing money?

As of the last Blueprint Medicines earnings report, Blueprint Medicines is currently losing money. Blueprint Medicines's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$67.09 million, a 86.77% decrease year over year.

What was BPMC's earnings growth in the past year?

As of Blueprint Medicines's earnings date in Invalid Date, Blueprint Medicines's earnings has grown year over year. BPMC earnings in the past year totalled -$67.09 million.

What are Blueprint Medicines's earnings expectations?

The current EPS estimate for Blueprint Medicines's earnings report in Invalid Date is -$1.66.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.